SmoM2 (W535L)-pcw107-V5 Citations (3)
Originally described in: Systematic identification of signaling pathways with potential to confer anticancer drug resistance.Martz CA, Ottina KA, Singleton KR, Jasper JS, Wardell SE, Peraza-Penton A, Anderson GR, Winter PS, Wang T, Alley HM, Kwong LN, Cooper ZA, Tetzlaff M, Chen PL, Rathmell JC, Flaherty KT, Wargo JA, McDonnell DP, Sabatini DM, Wood KC Sci Signal. 2014 Dec 23;7(357):ra121. doi: 10.1126/scisignal.aaa1877. PubMed Journal
Articles Citing SmoM2 (W535L)-pcw107-V5
Articles |
---|
Truncated BRPF1 Cooperates with Smoothened to Promote Adult Shh Medulloblastoma. Aiello G, Ballabio C, Ruggeri R, Fagnocchi L, Anderle M, Morassut I, Caron D, Garilli F, Gianno F, Giangaspero F, Piazza S, Romanel A, Zippo A, Tiberi L. Cell Rep. 2019 Dec 17;29(12):4036-4052.e10. doi: 10.1016/j.celrep.2019.11.046. PubMed |
MAPK15 Controls Hedgehog Signaling in Medulloblastoma Cells by Regulating Primary Ciliogenesis. Pietrobono S, Franci L, Imperatore F, Zanini C, Stecca B, Chiariello M. Cancers (Basel). 2021 Sep 29;13(19). pii: cancers13194903. doi: 10.3390/cancers13194903. PubMed |
The developmental stage of the medulloblastoma cell-of-origin restricts Sonic hedgehog pathway usage and drug sensitivity. Smit MJ, Martini TEI, Armandari I, Bockaj I, Zomerman WW, de Camargo Magalhaes ES, Siragna Z, Meeuwsen TGJ, Scherpen FJG, Schoots MH, Ritsema M, den Dunnen WFA, Hoving EW, Paridaen JTML, de Haan G, Guryev V, Bruggeman SWM. J Cell Sci. 2022 Jun 1;135(11):jeb258608. doi: 10.1242/jcs.258608. Epub 2022 Jun 8. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.